Better Artificial Intelligence (AI) Software Stock: Palantir vs. CrowdStrike
The Motley Fool· 2024-11-15 20:15
公司产品 - Palantir有领先的软件产品其2024年股票上涨约258%是今年表现最好的股票之一公司制作特定用例构建的AI软件其最新产品AIP有助于在企业内部集成大型语言模型[1] - CrowdStrike是一家网络安全公司通过Falcon平台提供多种解决方案其端点保护软件可保护网络接入点免受威胁并提供28个扩展模块[4] 公司业务增长与财务状况 - Palantir最新季度营收同比增长30%至7.26亿美元预计第四季度营收约为7.69亿美元(增长27%)[6] - CrowdStrike在2025财年第二季度(截至7月31日)营收增长32%至9.64亿美元年度经常性营收(ARR)增长32%至38.6亿美元预计第三季度营收约为9.82亿美元(增长25%)[8] 公司估值 - Palantir目前的市销率为55倍[10] - CrowdStrike的市销率为24.18倍[11]
Billionaire Steve Cohen Is Selling This Hot Artificial Intelligence (AI) Stock
The Motley Fool· 2024-11-15 20:15
关于Broadcom公司股价与市场表现 - AI投资是2023 - 2024年市场的主要主题且可能延续到2025年Broadcom是许多投资者追捧的AI股票之一其股价今年上涨约60%是市场上的佼佼者股价与其他表现强劲的AI股票相同[1] - 由亿万富翁Steve Cohen经营的Point72在第二季度大幅削减其Broadcom持股出售了三分之二的股份出售后该头寸占其总持股的0.79%而原来的权重相当大[2] 关于Broadcom公司业务情况 - 公司在硬件和软件行业有许多业务和产品在软件方面有网络安全解决方案大型机软件和企业软件最著名的产品是VMware去年以690亿美元收购了VMware[4] - VMware为客户提供访问虚拟计算机的权限使一台计算机可以运行多个桌面有助于客户更有效地利用服务器的计算能力是一款非常受欢迎的产品[5] - 在硬件方面VMware与AI联系更紧密其网络交换机如Tomahawk 5和Jericho3 - AI被许多AI超大规模企业用于数据中心以引导网络流量实现最高效率还设计定制AI加速器[6] - 该业务部门发展迅猛以太网交换机业务在第三季度同比增长超过300%AI加速器增长超过250%但公司规模太大其他表现不佳的业务部门掩盖了这些强劲业务的影响[7] 关于Broadcom公司财报与估值 - 2024财年第三季度(截至8月4日)营收同比增长47%但如果剔除VMware收购的影响增长率将降至仅4%[8] - 预计2025财年平均有37位华尔街分析师预计营收增长17%每股收益(EPS)增长28%目前的交易价格是2025年预期收益的24倍与其他AI领导者如台积电Meta和Alphabet处于几乎相同的类别但在这三者中其2025财年的市盈率是最贵的不过前景相似[9][10] 关于投资决策 - 投资者需要决定Broadcom是否是一个好的选择公司在某些领域有成功的产品线但在其他领域正在挣扎与其他三家没有明显弱点的公司相比更倾向于选择其他三家公司的股票虽然可能不像Steve Cohen和Point72那样直接抛售但有其他投资选择[11]
Elon Musk adds Microsoft as a defendant in OpenAI lawsuit, accusing them of anticompetitive conduct
Business Insider· 2024-11-15 20:14
文章核心观点 - Elon Musk将微软加入对OpenAI的修正诉讼中并指控微软与OpenAI形成垄断 [1][2] 诉讼相关情况 - 诉讼于周四提起还将Reid Hoffman列为被告同时将Musk的xAI以及Shivon Zilis列为原告Zilis曾是OpenAI董事会成员现在是Neuralink高管 [3] - 诉讼指控OpenAI和微软创造AI垄断并存在反竞争行为例如用丰厚薪酬吸引人才OpenAI计划为1500名员工花费15亿美元且有员工年薪达80万美元工程岗位薪酬在20万到37万美元之间 [4] - 律师称被告在生成式AI市场占有近70%份额构成垄断或企图垄断 [5] - 此次诉讼是Musk与OpenAI长期竞争的最新升级Musk曾于3月起诉OpenAI后撤诉8月再次起诉称OpenAI背离造福人类的初衷 [6] - 当前诉讼称OpenAI在最近一轮融资中要求投资者不投资竞争对手包括xAI [7] 相关方回应 - 微软OpenAI和Hoffman未立即回应Business Insider在非工作时间的置评请求9月Hoffman称Musk的诉讼是酸葡萄心理 [8]
One Stock I've Been Buying This Month And One I'm Looking To Buy
Seeking Alpha· 2024-11-15 20:10
With Donald Trump re-elected for a second term, the stock market has rallied. Particularly, companies in the financial and technology sectors have benefitted, seeing their share prices rise to new 52-week highs.Contributing analyst to the iREIT+Hoya Capital investment group. The Dividend Collectuh is not a registered investment professional nor financial advisor and these articles should not be taken as financial advice. This is for educational purposes only and I encourage everyone to do their own due dili ...
Energy Transfer Vs. Williams Companies: Only One Is A Buy
Seeking Alpha· 2024-11-15 20:05
Two of the biggest winners in the midstream space over the past three years have been Energy Transfer (NYSE: ET ) and Williams Companies (NYSE: WMB ). Neither of these stocks generates much hype in the broader financial media, but theyIf you want access to our Portfolios that have crushed the market since inception and all our current Top Picks, join us for a 2-week free trial at High Yield Investor.We are the fastest growing high yield-seeking investment service on Seeking Alpha with a perfect 5/5 rating f ...
3 Stocks Near 52-Week Lows That Could Be Top Buys Right Now
MarketBeat· 2024-11-15 20:01
Every once in a while, investors will come across a few relatively undeniable opportunities that cannot be passed by. Some of these opportunities begin with a selloff in a stock or a group of stocks. This is where investors can look past the noise and get to the nitty-gritty of what is actually happening behind the scenes. Today, three stocks trade near their 52-week lows, a signal that could be taken as a potential buy opportunity under the right circumstances. The right circumstances could be fundamental ...
3 Things You Need to Know If You Buy PayPal Stock Today
The Motley Fool· 2024-11-15 20:00
Shares of the fintech enterprise have surged in the past few months.Since its founding more than two decades ago, PayPal (PYPL -1.74%) has become a leader in the digital payments arena. However, in the past few years, it has become a disappointment for investors.Shares of PayPal currently trade about 70% below the all-time high they touched in 2021, even though they have soared by more than 40% in the past four months. That combination might have you considering this fintech stock as an investment candidate ...
Down 88%, This Growth Stock Could Be Set for a Recovery in 2025
The Motley Fool· 2024-11-15 20:00
Tech stocks saw a boom year in 2021 as they soared through the tail end of the pandemic. But tech stocks that went public during that year got stuck between a bull and bear market.Amplitude (AMPL -1.76%) is one such example. The software-as-a-service stock, which specializes in digital analytics and digital product optimization, went public in September 2021. The stock initially soared out of the gate on the broader enthusiasm for the software sector and the company's strong growth at the time of its market ...
Why Block Stock Was Winning This Week
The Motley Fool· 2024-11-15 20:00
One company that likely won't be happy to exit this week is Block (SQ -2.80%). Its stock was on the rise across the past few trading days thanks to a set of fresh -- and bullish -- evaluations of the fintech by analysts tracking its fortunes.As a consequence its share price had risen nearly 12% week to date as of Thursday night, according to data compiled by S&P Global Market Intelligence.Post-earnings updatesSomewhat counterintuitively, that cluster of positive new evaluations for Block came on the heels o ...
United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles Loom
Seeking Alpha· 2024-11-15 20:00
United Therapeutics Corporation (NASDAQ: UTHR ) is at the forefront of innovation in the biotechnology and pharmaceutical industry. Its portfolio of FDA-approved products treats pulmonary arterial hypertension (PAH) and related cardiovascular conditions. The company's wide treatment options, including oral and injectable therapies like Orenitram, Remodulin, and Adcirca, strengthenMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politec ...